Skip to main content
. 2019 Mar 14;7:e6612. doi: 10.7717/peerj.6612

Table 3. Univariate and multivariate analyses for overall metastasis.

Parameter Univariate analysis Multivariate analysis
HR (95% CI) P-value HR (95% CI) P-value
Age ≥60 years 1.00 [0.87–1.16] 0.959 0.95 [0.82–1.10] 0.490
Gender. male 1.00 [0.86–1.17] 0.97 1.10 [0.94–1.29] 0.248
T category
 T1 1 1
 T2 2.23 [1.71–3.10] <0.001 1.90 [1.40–2.57] <0.001
 T3 2.29 [2.12–3.99] <0.001 1.92 [1.39–2.65] <0.001
 T4 3.29 [2.44–4.42] <0.001 1.97 [1.45–2.67] <0.001
N category
 N0 1 1
 N1 1.52 [1.11–2.11] 0.010 1.28 [0.92–1.77] 0.141
 N2 3.19 [2.56–3.97] <0.001 2.41 [1.92–3.02] <0.001
 N3 3.87 [3.07–4.88] <0.001 2.52 [1.97–3.22] <0.001
Histology squamous 0.78 [0.67–0.92] 0.002 0.75 [0.64–0.88] 0.001
ALT or AST ≥40 U/L 1.30 [1.04–1.62] 0.023 1.14 [0.90–1.44] 0.285
Hepatitis virus 1.26 [1.03–1.54] 0.026 1.21 [0.98–1.50] 0.071
Diabetes mellitus 1.0 2 [0.79–1.31] 0.898 1.09 [0.84–1.41] 0.520
BMI ≥25 kg/m2 1.13 [0.96–1.33] 0.152 1.05 [0.89–1.24] 0.584
Hepatic steatosis 1.03 [0.88–1.21] 0.693 0.99 [0.84–1.17] 0.895
Surgery 0.38 [0.32–0.49] <0.001 0.53 [0.44–0.64] <0.001
Chemotherapy 2.07 [1.52–2.82] <0.001 1.22 [0.89–1.67] 0.224
Radiotherapy 1.43 [1.23–1.67] <0.001 1.13 [0.97–1.33] 0.119

Note:

ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HR, hazard ratio; CI, confidence interval.